The impact of scientific models on clinical psychopharmacology: a psychiatrist's view.
D000928:Antidepressive Agents; D001008:Anxiety Disorders / Q000175:diagnosis; D001291:Attitude of Health Personnel; D001521:Behavior Therapy; D001921:Brain / Q000378:metabolism; D003216:Conditioning, Operant; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism; D008954:Models, Biological; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism; D010554:Personality Disorders / Q000175:diagnosis; D010698:Phobic Disorders / Q000175:diagnosis; D011570:Psychiatry; D011600:Psychopharmacology; D012107:Research Design; D013329:Structure-Activity Relationship
D000928:Antidepressive Agents; D004295:Dihydroxyphenylalanine; D004298:Dopamine